Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Valeant Pharmaceuticals Intl (VRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 4,759,409
  • Shares Outstanding, K 347,910
  • Annual Sales, $ 9,674 M
  • Annual Income, $ -2,409,000 K
  • 36-Month Beta -0.34
  • Price/Sales 0.47
  • Price/Cash Flow 0.93
  • Price/Book 1.15

Price Performance

See More
Period Period Low Period High Performance
1-Month
11.80 +31.36%
on 05/31/17
15.73 -1.46%
on 06/22/17
+2.05 (+15.24%)
since 05/22/17
3-Month
8.31 +86.52%
on 04/24/17
15.73 -1.46%
on 06/22/17
+4.79 (+44.72%)
since 03/22/17
52-Week
8.31 +86.52%
on 04/24/17
32.75 -52.67%
on 08/24/16
-6.14 (-28.37%)
since 06/22/16

Most Recent Stories

More News
Bausch + Lomb Named Most Trusted Contact Lens Solution Brand In Canada For Second Consecutive Year By Brandspark International

20,000 Canadian Consumers Voted Across Multiple Categories for Most Trusted Consumer Packaged Goods Brands

VRX.TO : 20.51 (+12.57%)
VRX : 15.50 (+13.30%)
Bausch + Lomb Named Most Trusted Contact Lens Solution Brand In Canada For Second Consecutive Year By Brandspark International

20,000 Canadian Consumers Voted Across Multiple Categories for Most Trusted Consumer Packaged Goods Brands

VRX.TO : 20.51 (+12.57%)
VRX : 15.50 (+13.30%)
Corporate News Blog - Billionaire Hedge Fund Manager John Paulson Elected to Valeant Pharma's Board

LONDON, UK / ACCESSWIRE / June 21, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Valeant Pharmaceuticals International, Inc. (NYSE: VRX), following...

VRX : 15.50 (+13.30%)
VRX Investor Alert: Kyros Law is Investigating Legal Claims on Behalf of Valeant Pharmaceuticals Intl (NYSE: VRX) Investors

Kyros Law Offices is alerting investors of Valeant Pharmaceuticals Intl (NYSE: VRX) that it is investigating legal claims against the company for possible securities fraud violations committed by Valeant...

VRX : 15.50 (+13.30%)
Company News for June 20, 2017

Companies in the News are: RICE,EQT,RIGL,NVDQ,SYK,VRX

NVDQ : 11.80 (-0.17%)
SYK : 141.22 (+0.30%)
EQT : 52.03 (+2.36%)
RIGL : 2.78 (+2.58%)
VRX : 15.50 (+13.30%)
RICE : 24.03 (+1.87%)
Today's Research Reports on Stocks to Watch: Clovis Oncology and Valeant Pharmaceuticals

NEW YORK, NY / ACCESSWIRE / June 20, 2017 / Clovis Oncology soars to a share price it hasn't seen in almost two years after revealing positive trial results for its ovarian cancer drug Rubraca. Shares...

CLVS : 96.78 (+2.64%)
VRX : 15.50 (+13.30%)
Valeant names Arthur J. Shannon as SVP & head of Investor Relations and Communications

Pharmaceutical company Valeant Pharmaceuticals International Inc (NYSE:VRX)(TSX:VRX) announced on Monday the election of Arthur J. Shannon as senior vice president and head of its Investor Relations and...

VRX.TO : 20.51 (+12.57%)
VRX : 15.50 (+13.30%)
Valeant Appoints Arthur J. Shannon As Senior Vice President, Head Of Investor Relations And Communications

Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ("Valeant") today announced Arthur J. Shannon has joined the company as senior vice president, head of Investor Relations and Communications....

VRX.TO : 20.51 (+12.57%)
DYN : 8.24 (+2.62%)
VRX : 15.50 (+13.30%)
PRGO : 74.65 (+1.80%)
Valeant Appoints Arthur J. Shannon As Senior Vice President, Head Of Investor Relations And Communications

Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ("Valeant") today announced Arthur J. Shannon has joined the company as senior vice president, head of Investor Relations and Communications....

VRX.TO : 20.51 (+12.57%)
DYN : 8.24 (+2.62%)
VRX : 15.50 (+13.30%)
PRGO : 74.65 (+1.80%)
After Yesterday's Rally of 5.91% Shares Could Potentially Pullback

Valeant Pharmaceuticals International (NYSE:VRX) traded in a range yesterday that spanned from a low of $12.99 to a high of $13.63. Yesterday, the shares gained 5.9%, which took the trading range above...

VRX : 15.50 (+13.30%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators mostly agree with the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More

Business Summary

Valeant Pharmaceuticals International, Inc. is a pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics. The Company produces medicines that meet the special health problems of patients....

See More

Support & Resistance

2nd Resistance Point 17.05
1st Resistance Point 16.27
Last Price 15.50
1st Support Level 14.18
2nd Support Level 12.87

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.